李·西尔弗曼语音治疗 (LSVT-LOUD) 在帕金森型多重系统缩 (MSA-P) 的有效性:一个案例报告
Koji Hayashi1, Rina Izumi1, Namie Saito1
1Department of Rehabilitation Medicine, Fukui General Hospital, Fukui, JPN.
Cureus
|December 9, 2024
概括
李·西尔弗曼语音治疗 (LSVT-LOUD) 改善了帕金森型多系统缩 (MSA-P) 患者的言语和吞能力. 治疗还增强了额叶功能,这表明对MSA-P患者有潜在的益处.
科学领域:
- 神经学 神经学
- 语音语言病理学 语言病理学
背景情况:
- 多系统性缩-帕金森症类型 (MSA-P) 是一种渐进的神经退行性疾病.
- 患有MSA-P的患者往往会出现显著的运动,言语和吞障碍.
- 目前对MSA-P的治疗方法提供有限的症状缓解.
研究的目的:
- 为了研究李·西尔弗曼语音治疗-大声 (LSVT-LOUD) 在被诊断为MSA-P.P.的患者的疗效.
- 评估LSVT-LOUD对MSA-P的语言,吞和认知功能的影响.
主要方法:
- 一个75岁的男性被诊断患有MSA-P.的案例研究.
- 诊断工具包括MRI,DAT-SPECT和123I-MIBG心脏扫描仪.
- 患者接受了LSVT-LOUD治疗,治疗严重的消化不良和声.
主要成果:
- 在LSVT-LOUD之后,患者表现出语音音量和舌头压力的改善.
- 语音 (pa,ta,ka) 的交替运动速率和前额评估电池 (FAB) 评分也得到了改善.
- 在L-dopa挑战测试中没有观察到显著的运动症状改善.
结论:
- 在患有MSA-P的患者中,LSVT-LOUD疗法可能对言语和吞功能有好处.
- 治疗也可能对前额叶功能产生积极影响.
- 需要使用更大的样本大小进行进一步的研究来证实这些发现.
相关概念视频
01:24Parkinson's Disease: Treatment
219
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
219
01:15Parkinson's Disease: Overview
479
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
479